Phenominer Database Results (5 results)

 

How to display a graph
Strain Phenotype Conditions Study Experiment Name Sex Age # of Animals Value Units SEM SD Method Method Duration Post Insult Type Post Insult Time Value Post Insult Time Unit Method Notes Record ID Study ID
DA.PVG.1AV1-(D4Rat23-D4Mit12)/Kini experimental autoimmune encephalomyelitis duration myelin oligodendrocyte glycoprotein (13-85 ug/200 ul) (for 34 days) Marta M, et al., Genes Immun. 2010 Jan;11(1):21-36. Epub 2009 Aug 13. central nervous system integrity trait female 0 days 18 6.0 d in vivo visual assessment 0.0 subcutaneous injection 34 days from 8 to 34 days 69430 892
DA.PVG.1AV1-(D4Rat23-D4Mit12)/Kini post-insult time to onset of experimental autoimmune encephalomyelitis myelin oligodendrocyte glycoprotein (13-85 ug/200 ul) (for 34 days) Marta M, et al., Genes Immun. 2010 Jan;11(1):21-36. Epub 2009 Aug 13. central nervous system integrity trait female 0 days 18 31.2 d in vivo visual assessment 0.0 subcutaneous injection 0 from 8 to 34 days 69429 892
DA.PVG.1AV1-(D4Rat23-D4Mit12)/Kini experimental autoimmune encephalomyelitis duration myelin oligodendrocyte glycoprotein (13-85 ug/200 ul) (for 40 days) Marta M, et al., Genes Immun. 2010 Jan;11(1):21-36. Epub 2009 Aug 13. central nervous system integrity trait female 0 days 14 18.4 d in vivo visual assessment 0.0 subcutaneous injection 40 days from 8 to 40 days 69417 892
DA.PVG.1AV1-(D4Rat23-D4Mit12)/Kini percentage of study population developing experimental autoimmune encephalomyelitis during a period of time myelin oligodendrocyte glycoprotein (13-85 ug/200 ul) (for 40 days) Marta M, et al., Genes Immun. 2010 Jan;11(1):21-36. Epub 2009 Aug 13. central nervous system integrity trait female 0 days 14 86.0 % in vivo visual assessment 0.0 subcutaneous injection 40 days from 8 to 40 days 69415 892
DA.PVG.1AV1-(D4Rat23-D4Mit12)/Kini post-insult time to onset of experimental autoimmune encephalomyelitis myelin oligodendrocyte glycoprotein (13-85 ug/200 ul) (for 40 days) Marta M, et al., Genes Immun. 2010 Jan;11(1):21-36. Epub 2009 Aug 13. central nervous system integrity trait female 0 days 14 11.2 d in vivo visual assessment 0.0 subcutaneous injection 0 from 8 to 40 days 69416 892